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Copper trafﬁckingenzymes, Cu,Zn superoxide dismutase (Sod1) and cytochrome c oxidase (CcO),
that require copper as a cofactor for their biological activity. The copper used for their metallation originates
from a conserved, bioactive pool contained within the mitochondrial matrix, the size of which changes in
response to either genetic or pharmacological manipulation of cellular copper status. Its dynamic nature
implies molecular mechanisms exist that functionally couple mitochondrial copper handling with other,
extramitochondrial copper trafﬁcking pathways. The recent ﬁnding that mitochondrial proteins with
established roles in CcO assembly can also effect changes in cellular copper levels by modulating copper
efﬂux from the cell supports a mechanistic link between organellar and cellular copper metabolism.
However, the proteins and molecular mechanisms that link trafﬁcking of copper to and from the organelle
with other cellular copper trafﬁcking pathways are unknown. This review documents our current
understanding of copper trafﬁcking to, and within, the mitochondrion for metallation of CcO and Sod1;
the pathways by which the two copper centers in CcO are formed; and, the interconnections between
mitochondrial function and the regulation of cellular copper homeostasis.
© 2008 Elsevier B.V. All rights reserved.1. Cellular copper distribution and homeostasisCopper ions are cofactors for a number of metalloenzymes and, as
such, are required for normal cell physiology. Copper deﬁciency and
overload syndromes in humans that result in the decreased activity of
these enzymes have severe clinical outcomes associated with the
impaired function of many tissues, including the brain, liver and heart.
In addition, copper has an established role in cell growth and pro-
liferation that may be distinct from that it serves as a catalytic moiety
in relevant cupro-proteins [1]. The properties that make copper an
ideal biological cofactor also allow it to potentiate free radical ge-
neration when unbound within the cell. Therefore, cells have evolved
mechanisms to balance global copper content, and to distribute copper
to different subcellular compartments. These mechanisms are based
primarily on the collective activity of copper transporters, chaperones
and molecules that chelate copper in biologically inert complexes.
1.1. Copper homeostasis: lesson learned from unicellular model organisms
Many of the concepts that are fundamental to our mechanistic
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l rights reserved.unicellular model organisms such as Saccharomyces cerevisiae, Enter-
ococcus hirae and Escherichia coli. Here, we will focus our attention
exclusively on the unicellular eukaryote S. cerevisiae. Copper enters
yeast in part through the Ctr1 family of permeases [2]. The high
afﬁnity copper uptake system consists of two related permeases, Ctr1
and Ctr3, that transport cuprous ions and whose function therefore
depends on the activity of metalloreductases, which reduce environ-
mental Cu(II) to Cu(I). Ctr1 forms a trimeric channel complex, and its
ectodomain has multiple MxxM sequence motifs that appear to
function as Cu(I) scavenging modules, effectively gathering extra-
cellular Cu ions for subsequent transport across the plasma mem-
brane. In the absence of Ctr1, yeast cells are copper-deﬁcient and
exhibit impaired copper-dependent activities. These include mito-
chondrial respiration, resistance to oxidative stress and high afﬁnity
iron uptake. In addition to Ctr1, yeast cells have low afﬁnity Cu(I)
permeases such as Fet4 and Smf1 [2]. Ctr2, a vacuolar copper exporter,
also functions to mobilize copper in response to Cu-deﬁcient
conditions; however, it can also mislocalize to the plasma membrane
and facilitate copper import into the cell [3].
Once in the cell, Cu(I) ions are transported to sites of utilization by
two soluble Cu(I)-binding metallochaperones, Atx1 and Ccs1 [4], which
facilitate Cu(I) insertion into target cupro-enzymes [5,6]. Ccs1 activates
Sod1 [7] by inserting Cu(I) into the newly synthesized apo-protein and
catalyzing the formation of an essential disulﬁde bond [8]. The
metallochaperone Atx1 shuttles Cu(I) to Ccc2, a P-type ATPase trans-
porter localized in the trans-Golgi network (TGN) [9]. P-type ATPases
translocate cations against an electrochemical potential gradient by
using theenergyderived fromATPhydrolysis. TGN luminal Cu(I) ionsare
Fig. 1.Mitochondrial copper trafﬁckingpathways:Apo-ligand is predominantlydistributed to
the cytosol. Bindingof copper results in its translocation/diffusion across the outermembrane
(OM) (via open channels inorange), and itsprotein-mediated transport (blue) across the inner
membrane (IM). The anionic ligand complex (CuL) is stored in themitochondrialmatrix in an
inert form that is biologically accessible. It is mobilized in response to what remain as poorly
understood signals/stimuli and transported across the IM by either the same transporter, or a
second transporter, where it is transferred to COX17 or CCS formetallation of relevant targets
(CcO and SOD1, respectively). CuLmay also be ‘recycled’ through the transporter for eventual
release to the cytosol (indicated by dashed arrow) in the absence of the copper chaperones or
under high copper conditions.
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where it functions in iron acquisition [10]. The eukaryotic Cu(I)-speciﬁc
P-type ATPases contain multiple Cu(I) binding modules in their N-
terminal domains. These modules structurally resemble Atx1 and serve
as docking sites for metallochaperone binding and subsequent Cu(I)
transfer via ligand exchange reactions [5,6].
Copper is required within the mitochondrion for the maturation of
CcO and Sod1 [11,12] (Fig. 1). Two copper-binding subunits of CcO, Cox1
and Cox2, are encoded by the mitochondrial genome, and their me-
tallation within the IMS depends on several CcO assembly factors, i.e.
Cox17, Sco1 and Cox11, that facilitate the formation of the Cu centers
contained within each structural subunit [13]. Metallation of IMS Sod1,
which represents approximately 1–5% of the total cellular Sod1 pool
[12], also occurswithin the IMS, since both it and its chaperone Ccs1 are
imported into the mitochondria as apo-molecules [14]. The fact that
metallation of CcO and Sod1 occurs within the organelle necessitates
that a speciﬁc pathway(s) exists for copper transport to the mitochon-
drion. Biochemical experiments have identiﬁed a bioavailable copper
pool within the matrix that is essential for these metallation reactions.
In fungi, balancing the need for copper with its potential toxicity is
regulated primarily at the level of gene transcription [15]. Cu-deﬁcient
growth conditions lead to an up-regulation of the high afﬁnity Cu(I)
permease family as well as the metalloreductase necessary for Cu(I)
import.Whengrown inexcess copper, toxicity isprecludedby the induced
transcription of Cu(I) buffering metallothioneins and post-transcriptional
internalization and degradation of Ctr1 molecules localized to the plasma
membrane [16]. Importantly, in the context of higher eukaryotes, yeast
lack a deﬁned copper export pathway. The only equivalent is import of
copper into the vacuole, which actually forms an additional cellular store
that can be accessed in a Ctr2-dependent manner [3,17].
1.2. Multicellular eukaryotes: added complexities of copper homeostasis
In contrast to unicellular organisms, copper homeostasis in
mammals requires that its levels and distribution be appropriatelybalanced at the cellular, tissue and systemic levels. Nutritional copper
is taken up in the diet and distributed throughout the body in serum,
bound to proteins such as ceruloplasmin or albumin. Albumin-bound
copper is chelated by an unidentiﬁed, kinetically labile copper com-
plex [18,19]. The dynamics of its systemic transport will not be
discussed here.
Known mechanisms of cellular copper uptake and distribution are
largely similar to those described above for yeast. Eukaryotic cells have
a Ctr1 homolog that is expressed in all tissues, and mice that are
heterozygous at the CTR1 locus are growth impaired and show
developmental defects when compared with their wild-type litter-
mates, while a CTR1 null is embryonic lethal [20,21]. Animals inwhich
CTR1 has been conditionally knocked out in intestinal epithelial cells
exhibit a systemic copper deﬁciency, and all organs except for the
kidney are severely copper-deﬁcient. Partial rescue of the resultant
hypertrophic cardiomyopathy in these conditional mice is achieved
by a single intravenous injection of copper [22]. This observation
reinforces the fact that mammals possess a hierarchical regulatory
network that allows for the relative prioritization of copper at a whole
organism level.
After crossing the plasma membrane into cells, copper is dis-
tributed by the human orthologs of Atx1 and Ccs1; ATOX1 and CCS,
respectively. ATOX1 has awell established role in transporting Cu(I) to
the Menkes and Wilson P-type ATPases (ATP7A and ATP7B, respec-
tively), and was recently shown to have a novel role in shuttling Cu(I)
ions to the nucleus where it is involved in the transcriptional activa-
tion of cyclin D1 gene expression [1]. ATP7A and ATP7B are two
homologous proteins with the analogous function but with essentially
non-overlapping expression patterns across tissues [23–26]. ATP7A
translocates Cu(I) into the lumen of the TGN for incorporation into
secreted cupro-enzymes, including tyrosinase, dopamine β monoox-
ygenase, peptidylglycine α-amidating monooxygenase and super-
oxide dismutase-3 [27]. However, it also trafﬁcks to the cell periphery
to efﬂux Cu(I) ions in response to high cellular Cu concentrations and,
accordingly, an increase in ATP7A copy number in CHO cells confers a
hyper-resistant phenotype to growth in elevated copper salts [28]. In
contrast, loss-of-function mutations in the ATP7A gene cause Menkes
disease, a disorder in which defective copper transport from en-
terocytes into the general circulation produces a severe copper
deﬁciency in several tissues, in particular the brain [29]. Mutations in
ATP7B result in Wilson's disease, a condition in which patients suffer
from copper overload in the liver due to an inability to export copper
into the bile, the main pathway for its excretion from the body. ATP7B
also transports Cu(I) into the lumen of the hepatic TGN for its
incorporation into ceruloplasmin. Thus, the function of both ATP7A
and ATP7B is critical not only to the metallation of cupro-enzymes
within the secretory pathway but also to the removal of excess copper
from the cell.
The amyloid precursor protein (APP), a member of a family of
related proteins, APLP1 and APLP2, has been proposed to modulate
copper efﬂux from the liver and cerebral cortex [30], andmay therefore
represent yet another copper trafﬁcking pathway crucial to the
regulation of cellular copper homeostasis. However, the mechanism
of APP-mediated copper export from the cell has yet to be resolved,
although APP contains a copper-binding site within its extracellular
domain [31].
Copper homeostasis in mammalian cells is achieved in part by
several distinct post-transcriptional regulatory processes. First, copper
uptake by Ctr1 is responsive to copper status. Elevated copper levels
result in diminished abundance of Ctr1 at the plasma membrane
through its endocytosis and subsequent degradation [32]. In adult
mice, its predominant localization to intracellular vesicles suggests
that, at least in this organism, copper levels are such that signiﬁcant
changes in its high afﬁnity uptake are not generally required under
normal physiological conditions. Second, the subcellular localization
of ATP7A and ATP7B is sensitive to cellular copper status, with each
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vesicles, respectively, in response to elevated copper levels [33]. The
differential Cu-regulated trafﬁcking of each ATPase to either apical or
basolateral surfaces is likely mediated by accessory proteins and
multiple sorting signals within their C-terminal tails [34]. Third, the
abundance of several proteins is tightly coupled to cellular copper
status. Elevated copper levels, for example, induce the degradation of
CCS in a process that couples changes in cellular copper content with
the activation of Sod1 [35,36]. Copper can also control the activity and
abundance of the E3 ubiquitin ligase XIAP, X-linked inhibitor of
apoptosis [37,38]. Copper binding to XIAP induces a conformational
change that results in its inactivation and proteosomal degradation.
These changes in XIAP levels in turn affect the abundance of COMMD1,
a multifunctional, cytosolic protein implicated in controlling copper
export from the cell through ATP7B [39].
Traditionally, copper trafﬁcking pathways have been studied in
isolation; however, experimental evidence is beginning to accumulate
that supports the idea that dynamic communication between in-
dividual copper trafﬁcking pathways is critical to how global decisions
are made about cellular copper handling and distribution. One such
connection linking two discrete copper trafﬁcking pathways involves
APP and Sod1. The formation of a 40–42 residue Aβ peptide derived
from APP, the potential copper export molecule, is initially catalyzed
by the aspartic protease BACE1. BACE1 can bind Cu(I) and this leads to
an interaction with Ccs1 which may in turn serve to modulate the
Ccs1-dependent activation of Sod1 [40]. A second example of such an
interconnection links the functions of Sco1 and Sco2, two proteins
with established functions in CcO assembly, with the regulation of one
or more extramitochondrial pathways that modulate copper efﬂux
from the cell [41] (see section 4).
2. Copper in the mitochondria: CuA and CuB site formation
The essential nature of copper in the mitochondria is derived from
the role it plays in the utilization of oxygen (CcO) and the protection
it affords against oxidative stress (Sod1). CcO contains multiple co-
factors critical to its catalytic competence, and their delivery and
insertion into the nascent holoenzyme complex require multiple an-
cillary proteins [13]. The subunits of CcO that form the catalytic core of
the enzyme, Cox1–Cox3, are encoded by the mitochondrial genome
[42]. Two heme a moieties and three copper ions are contained with-
in conserved domains of Cox1 (a, a3, CuB) and Cox2 (CuA) [11]. The
mononuclear CuB site in Cox1 interacts with heme a3 to form a
heterobimetallic heme a3–CuB center, while the CuA site contained
within Cox2 exists as a cysteine-bridged, binuclear, mixed valent
center. The catalytic core is surrounded by nuclear-encoded structural
subunits, which confer stability to the holoenzyme and provide sites
for the allosteric regulation of its activity [43]. The fully assembled
holoenzyme is embedded within the inner mitochondrial membrane
(IM), and is further organized into higher order structures termed
supercomplexes in yeast and mammals [44].
The insertion of copper into Cox1 and Cox2 in the IMS appears to
mirror the copper chaperone paradigm from the cytosol. That is,
copper is inserted bycopper-binding chaperones and co-chaperones at
speciﬁc stages of holoenzyme assembly, which in mammalian cells
proceeds in amodular fashion [45]. Cox17 acts as the copper chaperone
that delivers copper to both Sco1 and Cox11 in yeast, donating Cu(I) to
each molecule through transient interactions that are mediated by
distinct structural interfaces [46]. Its ability to load human SCO1 in
vitro, along with the observation that COX17 null mice are embryonic
lethal, is consistent with the conservation of its function in higher
eukaryotes [47]. Although Cox17 readily adopts multiple oligomeric
states and is capable of forming distinct Cu(I) conformers, it now
appears that the bioactive conformer consists of a single Cu(I) ion
coordinated to a monomeric protein that is stabilized by two disulﬁde
bonds [48]. Cox17 has two additional conserved Cys residues upstreamof the ﬁrst Cys of the twin Cx9C motif, and these vicinal Cys residues
coordinate Cu(I) in a bent, two coordinate complex [49]. The redox
couple of the double disulﬁde conﬁguration to the fully reduced state
has amidpoint potential of −340mV, consistentwith the dual disulﬁde
molecule being a likely species in vivo [50].Mutational analyses further
reveal that Cu(I) coordination and Cox17 function are not dependent
on the presence of two disulﬁde crosslinks [51].
In yeast, Sco1 and Sco2 were ﬁrst identiﬁed as high copy
suppressors of a COX17 null [52]. Yeast lacking Sco1 fail to grow on a
non-fermentable carbon source, and thorough genetic and biochem-
ical analyses clearly implicate Sco1 in the formation of the mixed
valent CuA site in Cox2 [53]. Deletion of SCO2 does not result in a
respiratory defect, and to date, its function in yeast remains unknown.
In contrast, both SCO1 and SCO2 are required in humans for viability
[54].Mutations in either gene produce a severe, isolatedCcOdeﬁciency
that results in early onset disease with a fatal clinical outcome;
however, SCO2 patients present with neonatal encephalocardiomyo-
pathy, whereas SCO1 patients exhibit neonatal hepatic failure. The
distinctive clinical presentation is not a result of tissue-speciﬁc ex-
pression of the twogenes, as SCO1 and SCO2 areubiquitouslyexpressed
and exhibit a similar expression pattern in different human tissues.
Studies with immortalized ﬁbroblasts derived from SCO1 and SCO2
patients suggest that SCO1 and SCO2 have non-overlapping but
cooperative functions in CcO assembly [54].
Sco1 and Sco2 are tethered to the IM by a single transmembrane
helix with the C-terminal globular domains protruding into the IMS
[55,56]. A single Cu(I) binding site exists within the globular domain of
Sco1 and Sco2, consisting of two cysteinyl residues within a Cx3Cmotif
and a conserved histidyl residue. Mutation of either the Cys or His
residues in Sco1 or Sco2 abrogates Cu(I) binding and results in
decreased CcO activity [55,56]. Studies in organisms with a single Sco,
such as Bacillus subtilis, suggest that the copper in Sco1 is transferred
to CcO [57]. The Cu(I) ion coordinated by Sco1 is solvent-exposed and
poised for ligand exchange transfer reactions. The structures of the
metal-free Sco1 and Cu1Sco1 complex are similar, with only one loop
showing signiﬁcant rearrangements [58]. The movement of this loop
orients the Cu(I) binding His residue in the proper orientation for Cu
binding [58]. The structural dynamics of loop 8 suggest that it may be
an important interface for interactionswith Cox17 and/or Cox2 [59]. In
addition to binding Cu(I), Sco proteins bind Cu(II) [60]; however, it is
not clear whether Sco1 transfers both Cu(I) and Cu(II) ions to build the
mixed valent, binuclear CuA site in Cox2. The human SCO2 conformer
resembles human SCO1, although it exhibits greater conformational
dynamics [61]. While copper binding is also required for its function,
whether the copper is transferred to CcO or is necessary for SCO2 to
facilitate an aspect of SCO1 function during CcO assembly remains
equivocal.
Cu(I) binding to Cox17, Sco1 and Sco2 necessitates that the Cu(I)-
binding cysteines be maintained in the reduced state during the Cu(I)
transfer reactions. Mutations that alter the redox state or Cu(I) binding
capacity of any of these proteins are expected to attenuate CcO as-
sembly. Although no mutations in human COX17 have been described,
missense mutations identiﬁed in SCO1 (P174L) and SCO2 patients
(C133S, E140K and S240F) are located within or adjacent to the con-
served Cx3C and essential His residues. The P174L substitution in
human SCO1 does not affect the ability of the protein to bind and retain
either Cu(I) or Cu(II) [62], yet its function in vivo is severely com-
promised as evidenced by the pronounced CcO assembly defect in
SCO1 patient tissues and ﬁbroblasts [54]. Further study of the P174L
mutant SCO1 using both in vitro and in vivo assays revealed that the
amino acid substitution impairs its ability to be metallated by Cox17
[62], and this likely represents the molecular basis for the inefﬁcient
assembly of the CcO complex in this genetic background. In contrast, it
appears that mutations in SCO2 largely affect protein dynamics,
altering the quaternary structure of the protein in such a way that
promotes its degradation and ultimately leads to very low, residual
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residual function of the common E140K SCO2 mutant is corroborated
by the observations that the recombinant protein retains the ability to
bind copper, albeit less stably [63], and that its overexpression in SCO2
patient cell lines functionally complements the CcO deﬁciency [54].
Like Sco1 and Sco2, IM-tethered Cox11 has a single transmembrane
helix with a C-terminal domain that contains its cysteinyl copper-
binding residues protruding into the IMS. It is thought to be required
for CuB site formation, given that yeast cells lacking Cox11 have
impaired CcO activity and lower levels of Cox1, but still maintain the
ability to transiently form the heme a3 site [64,65]. Cysteinyl residues
within its C-terminus are important for Cu(I)-binding and correlate
with in vivo function such that, when mutated, Cu(I) binding is
abrogated and CcO activity is attenuated [66,67]. A speciﬁc role for
Cox11 in the biogenesis of the CuB site is also supported by the
observation that CcO isolated from Rhodobacter sphaeroides cox11Δ
cells lacked CuB but contained bothhemes. Cu(I) transfer fromCox11 to
Cox1 to form the CuB site likely occurs concurrently with the insertion
of heme a3 as nascent Cox1 chains are being inserted into the IM, since
the heterobimetallic site lies 13 Å below the membrane surface in the
mature holoenzyme [67,68].
3. Source of copper for CcO and Sod1 assembly
Copper ions used in the metallation of CcO and Sod1 are derived
from a low molecular weight copper complex within the mitochon-
drial matrix whose biochemical characteristics are conserved from
yeast to humans [69], arguing that its functional importance arose
early on in evolution and has since been retained. Although the
structure of the ligand has yet to be elucidated, it stably binds Cu(I)
in an anionic complex that can be depleted by the targeted expres-
sion of two heterologous Cu(I) binding molecules, human SOD1 or
yeast Crs5 metallothionein [70]. The functional consequence of
attenuating the CuL pool is apparent in Cu-limited cells, where the
presence of either competitor molecule within the matrix diminishes
CcO activity and, as a result, impairs growth on non-fermentable
carbon sources. Matrix targeted Crs5 expression also reduces Sod1
protein levels within the IMS and impairs activity of an IM-tethered
human SOD1. Supplementation of the cultureswith exogenous Cu salts
causes a signiﬁcant expansion in the matrix CuL pool and reverses
the observed phenotypes, arguing that it is the source of copper used
in the metallation of CcO and Sod1 within the IMS.
The matrix CuL complex appears to be a storage depot for Cu(I)
ions destined for CcO and Sod1 metallation reactions in the IMS
(Fig. 1). How Cu(I) is trafﬁcked to the mitochondria and subsequently
translocated to the matrix for its storage remains an open question.
Although the presence of Ccs1 and Cox17 in both the cytosol and IMS
made them attractive candidates as mitochondrial Cu(I) shuttles,
yeast lacking Ccs1 or Cox17 retain normal or near wild-type levels of
mitochondrial copper, respectively [69]. Ccs1-depleted yeast also have
wild-type CcO activity and the CcO deﬁciency in cox17Δ cells is
functionally complemented by restricting Cox17 localization to the
IMS using a heterologous IM membrane-binding domain [71]. Thus,
neither protein participates in Cu(I) transport and delivery to the
organelle. Cox19 and Cox23 are two additional cysteine-rich, soluble
proteins which are also present in both the cytosol and IMS; however,
like Cox17, their deletion has modest effects on mitochondrial copper
levels [69].
While the CuL complex is localized largely to the mitochondrial
matrix, the Cu-free ligand is abundant within the cytosol [70] (Cobine,
Leary, Winge and Shoubridge, unpublished results) (Fig. 1). Cu(I) bind-
ing to the apo-ligand yields an anionic complex that shares the known
biochemical characteristics of the authentic matrix Cu(I) complex.
We therefore postulate that Cu(I) binding to the ligand within the
cytosol triggers the translocation of the anionic CuL complex to the
mitochondrion. This model is a novel paradigm of copper trafﬁckingdistinct from that of the metallochaperone systems in the cytosol.
The facile expansion of the matrix CuL pool upon supplementation of
cells with exogenous copper is consistent with the CuL translocation
model, and with the high level of apo-ligand in the cytosol. Yeast cells
depleted of Cup1, which serves to buffer against changes in cytosolic
copper levels, exhibit an expansion of the matrix CuL pool over wild-
type yeast which is dramatically enhanced upon their growth in
copper salts. Thus, trafﬁcking of copper to the mitochondria is more
facile in cells unable to buffer copper in the cytosol, suggesting some
competition between the ligand and other cytosolic fates for copper.
The CuL complex translocation model predicts that transport occurs
both into and out of the matrix. Therefore, either two transporters or a
single bi-directional transporter exists within the IM. We postulate
that once the CuL diffuses through channels in the OM, a transporter
functions tomove it from the IMS into the matrix. Its regulated release
by a transporter would then result in the channeling of either Cu(I) or
the CuL complex from thematrix back to the IMS for subsequent use by
Cox17 and Ccs1 in downstream metallation reactions. The protein-
mediated regulation of transporter activity is supported by the
observation that the deletion of Coa1 and Shy1, two CcO assembly
factors with roles in Cox1 maturation, attenuates matrix copper levels
[72]. The regulation of the export step by a subset of proteins that
participate either in CcO assembly or Sod1 activationwould effectively
limit the amount of free copper within IMS, and may in fact have been
the driving force that necessitated the existence of the Cox17 copper
chaperone pathway in the IMS.
4. Mitochondrial regulation of cellular copper homeostasis
While most of the proteins responsible for trafﬁcking copper to,
within and frommitochondria have yet to be identiﬁed, it is clear that
the organelle contains the requisite machinery to acquire, maintain
and mobilize a bioactive pool of copper within its matrix. Copper is
present in vast molar excess of that required for the metallation of
these proteins, suggesting that the matrix copper pool fulﬁlls at least
one additional function. Its ability to either expand or contract in
response to changes in total cellular copper levels [69] (Cobine, Leary,
Winge and Shoubridge, unpublished data) further suggests that the
matrix copper pool could be a dynamic rheostat that responds to
changes in cellular copper status. Such a rheostatic role would pre-
sumably afford the organelle an opportunity to ensure the presence of
both an adequate supply and reserve of copper within mitochondria
for themetallation of its targets under all physiological conditions. The
fact that the pool can be expanded to amuch greater extent than it can
be depleted [69] (Cobine, Leary, Winge and Shoubridge, unpublished
data) supports the idea that the organelle's relative priority is to retain
sufﬁcient copper to metallate CcO and IMS Sod1.
Given that the mitochondrial inner membrane is impermeable, the
ability of thematrix copper pool to act as a rheostat is contingent upon
a signaling pathway that communicates information derived from
various mitochondrial compartments to relevant extramitochondrial
targets (Fig. 2). This requires innermembrane proteinswith functional
domains in both the matrix and IMS that are capable of sensing
relevant stimuli and transducing appropriate signals. It also depends
on either proteins or second messengers that monitor and report on
the functional state of these inner membrane proteins. Subsequent
transduction of the original signal could then be achieved by release of
the relevant molecule from the IMS to the cytosol, where it would
interact with effectors responsible for regulating the activity of other
cellular copper trafﬁcking pathways. Alternatively, the same signal
could be transduced by translocation of the protein or second mes-
senger to, and its interactionwith, the IMS side of an outer membrane
protein complex to which cytosolic effectors are either docked (and
released) or recruited (Fig. 2).
Attractive candidates to function in such a signaling pathway are
copper-binding proteins, given their ability to bind the substrate in
Fig. 2. Proposed mechanism of SCO-dependent regulation of cellular copper efﬂux:
The redox state of SCO1 (red) and SCO2's (blue) cysteine thiols exists in a dynamic
equilibrium between oxidized and reduced forms that is sensitive to cellular/mito-
chondrial copper status (A). Genetic interactions between SCO1 and SCO2 that are
relevant to both CcO assembly and the regulation of cellular copper homeostasis have
been demonstrated in human cells [54,41]. The P174L mutation (B, unﬁlled) or a
disproportionate shift in SCO1's cysteine sulfurs towards a reduced state (C), like that
observed in a SCO2 background, initiates a signaling cascade by abrogating an in-
teraction with a molecule/sensing protein. Release of either factor then transduces the
signal, by either translocating from the IMS to the cytosol (D) or interacting with an
outer membrane (OM) protein complex to which relevant effectors are docked or
recruited (E). The trafﬁcking of one of several potential cytosolic effectors, including
FKBP52, ATOX1, COMMD1 or an unknown factor(s), may in turn be sensitive to such a
signal, and through interactions with ATP7A or ATP7B, alter the rates of copper efﬂux
from the cell.
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(Cox11, Sco1 and Sco2) and 4 soluble, cysteine-rich (Cox17, Cox19,
Cox23 and Pet191) CcO assembly factors are localized to the IMS.
Changes in their abundance, cysteine thiol redox state or metallation
state are all therefore potential mechanisms whereby mitochondrial
signals relevant to either intra-organellar communication of copper
status or the activity of other copper trafﬁcking pathways within the
cell could be both generated and ﬁne tuned. The importance of redox
chemistry within the IMS to mitochondrial biology is an emerging
theme in the ﬁeld, and has been linked to protein import [73] and
the regulation of electron transport chain activity [74]. Thus, a role for
any of these proteins in a redox-dependent signaling pathway is not
without precedence.
4.1. SCO-dependent copper efﬂux
Consistent with a role for CcO assembly factors in the regulation of
cellular copper homeostasis, we recently demonstrated that affected
tissues from SCO patient backgrounds exhibit a copper deﬁciency
phenotype that likely contributes to the etiology of the associated
diseases [41]. A clear genotype–phenotype relationship was observedin the SCO2 background, with the copper deﬁciency being most severe
in ﬁbroblasts derived from those patients expressing a singlemissense
allele. Signiﬁcant reductions in copper levels are also observed in
multiple COX15 patient ﬁbroblast lines. In all three patient back-
grounds, the CcO and copper deﬁciency phenotypes are dissociable,
and overexpression of SCO2 increases cellular copper levels; however,
only a partial rescue of the latter phenotype is observed in the SCO1
background, due to active signaling by theP174L variant. Kinetic labeling
studies with 64Cu established that reduced cellular copper levels in both
SCO1 and SCO2 patient ﬁbroblasts are not caused by an inability to
acquire copper via its high afﬁnity uptake, but rather are attributable to a
defect in its cellular retention. Collectively, the ﬁndings of this study
argue that SCO1 and SCO2 are bifunctional molecules, with SCO2 acting
tomodify an aspect of SCO1 function that is crucial to the generation of a
signal that modulates the rate of copper efﬂux from the cell.
Howmight changes in the functional state of the SCOproteins effect
signals that are relevant to the regulation of cellular copper home-
ostasis? One mechanistic possibility is that signaling is sensitive to
changes in either their abundance or their relative ratio; however, the
cellular copper content in control ﬁbroblasts is unresponsive to several
fold changes in the abundance of either SCO protein [41], suggesting
that this is unlikely to represent a viable strategy with which to
modulate signaling in response to physiological cues in vivo. A more
likely mechanistic scenario by which SCO-dependent signaling could
be rapidly modulated is through changes in the redox state of SCO1's
cysteine thiols [41] (Fig. 2). Accordingly, we observe that; the cysteine
thiols of SCO1, but not those of other CcO assembly factors, are dis-
proportionately reduced in copper-deﬁcient COX10, COX15 and SCO2
patient backgrounds relative to controls; and, the ratio of its reduced to
oxidized cysteinyl sulfurs explains a signiﬁcant amount of the variation
in copper levels across these different genetic backgrounds (Leary,
Cobine, Winge and Shoubridge, unpublished data). While the cysteine
thiols of P174L SCO1 are entirely oxidized in SCO1 patient ﬁbroblasts
(Leary, Cobine, Winge and Shoubridge, unpublished data), we favor a
model in which this mutant protein elicits a signal equivalent to
the wild-type, copper-loaded SCO1 conformer, thus signaling a state
of cellular copper overload [75]. A causal role for the redox state of
SCO1's cysteine thiols in the aberrant signaling that results in a copper
deﬁciency phenotype in these patient backgrounds is supported by
two additional observations (Leary, Cobine, Winge and Shoubridge,
unpublished data); ﬁrst, the cysteine thiols of SCO1 are also dis-
proportionately reduced in ATP7A patient ﬁbroblasts, a genetic context
in which cellular copper levels are several fold higher than those in
controls [76]; and second, the cysteine thiols of SCO1 are shifted
towards an oxidized state in control ﬁbroblasts in which cellular
copper levels have beenpharmacologically depleted, a responsewhich
is signiﬁcantly attenuated in a SCO2 background. Although the pro-
teins) responsible for maintaining or altering the redox state of the
cysteine thiols of eitherhumanSCOprotein remains unknown, a recent
study reported that the Rhodobacter ortholog PrrC, a protein identiﬁed
as a regulator of photosynthesis, exhibits thiol-disulphide oxidore-
ductase activity [77]. Our most recent data suggest that human SCO2
also functions in such a capacity to modify the redox state of SCO1's
cysteine thiols, and that a shift in the total population of SCO1's
cysteine thiols towards a reduced state results in the generation of
a signal that increases the rate of copper efﬂux from the cell. The
potential contribution of disproportionate metallation of these
reduced cysteine thiols to the generation of this SCO-dependent
regulatory signal is being actively investigated.
At the organellar level, the mechanism(s) that senses and trans-
duces a SCO-dependent signal based on the redox state of SCO1's
cysteine thiols is completely unknown. Several soluble IMS proteins
with roles in either Sod1 activation (Ccs1) or CcO assembly (Cox19,
Cox23 and Pet191) represent potential candidates. CCS may impact
upon SCO-dependent signaling by competing for copper that is mobi-
lized from the matrix to metallate CcO within the IMS, effectively
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recent ﬁnding that transgenic mice overexpressing CCS and mutant
G93A SOD1 exhibit an isolated CcO deﬁciency in spinal cord [78];
however, additional studies are required that directly evaluate the
potential for crosstalk between IMS proteins that deliver copper to
Sod1 and CcO under more physiologically relevant conditions.
One or more of the aforementioned CcO assembly factors may also
play a role in regulating copper availability, either at the level of its
trafﬁckingwithin the IMS or its routing from the organelle. Thismay in
fact explainwhy there are somany cysteine-rich, soluble CcO assembly
factors within the IMS with poorly deﬁned roles in holoenzyme bio-
genesis. In yeast, mitochondrial copper levels are unaffected by the
single deletion of any of these genes, and the double deletion of COX17
and COX19; however, the inability to alter the mitochondrial copper
content in these mutants may reﬂect the fact that there is considera-
ble buffering capacity within the system, such that knockout of all
redundant components is required to observe a phenotype. Whe-
ther total cellular copper content is affected in any of these genetic
backgrounds has not been considered, and at present it is unclear how
much of a percent change in the total mitochondrial copper pool
is required to impact upon cellular copper status. Alternatively, the
transduction of a SCO-dependent signal may rely on other cytosolic
copper chaperones that do not participate directly in IMS Sod1 ac-
tivation or CcO assembly, such as COMMD1 or ATOX1 (Fig. 2). Sys-
tematic genetic and biochemical analysis of the potential involvement
of all candidates is required.
We have previously shown that SCO-dependent copper efﬂux from
the cell is not attributable to the altered abundance of known extra-
mitochondrial copper chaperones [41]. Indirect immunoﬂuorescence
studies of ATP7A localization in control and SCOpatientﬁbroblasts also
failed to reveal grossmislocalization of the protein to the cell periphery
in the patient backgrounds. If, however, only a small percentage of
the total cellular pool of ATP7A is required to effect changes in the
rate of copper efﬂux from the cell [79], this methodology may not
be sufﬁciently sensitive to detect subtle but biologically meaningful
changes in its cellular distribution. Indeed, two subsequent genetic
experiments implicate ATP7A in a SCO-dependent signaling pathway
that regulates copper efﬂux fromﬁbroblasts (Leary, Cobine,Winge, and
Shoubridge, unpublished data). First, cellular copper levels in ATP7A
patient ﬁbroblasts are unchanged upon overexpression of the P174L
SCO1 mutant following the knockdown of wild-type SCO1 below
immunologically detectable levels. Second, ATP7A knockdown in
control and SCO patient ﬁbroblasts results in a disproportionate
increase in cellular copper levels in the patient backgrounds. Whe-
ther the pathway being mapped in ﬁbroblasts is conserved in other
cell types remains an open question. It is possible that the basic
architecture of the efﬂux pathway is conserved, but that different
proteins fulﬁll the identical role in different cell types (Fig. 2). For
example, in the severely copper-deﬁcient liver of a SCO1 patient [41],
enhanced rates of copper efﬂux may be achieved by the inappropriate
activation of ATP7B, the homologue of ATP7A. Stimulation of copper
export by either ATPase may be achieved by interactions with either
COMMD1 or ATOX1. Alternatively, other mechanisms such as the
immunophilin-dependent regulation of copper efﬂux from the cell by
FKBP52 may be relevant [80]. An evaluation of the tissue-speciﬁcity of
copper efﬂux pathways, and their potential to explain the tissue-
speciﬁc etiology of disease observed in SCO patient backgrounds
awaits the generation of relevant transgenic models.
5. Perspectives and future outlook
Individual copper trafﬁcking pathways collectively regulate the
cellular concentration of copper ions within a fairly narrow range.
This ensures its appropriate distribution to key cupro-enzymes
and minimizes its potential toxicity. While these pathways have
been studied in isolation, the interplay between them has not beenthoroughly investigated. Here, we have focused our attention on SCO
proteins,whose functions lead to the intersection of pathways relevant
to both the assembly of the mitochondrial cupro-enzyme CcO and
cellular copper export.
Mitochondria have a vested interest in how cellular copper is
prioritized, based on the need to metallate CcO to sustain aerobic life,
and, as a major source of reactive oxygen species, to activate IMS SOD1
and control the levels of free copper within the cell. Organellar sig-
naling for the redistribution of copper in response to metabolic need
is not without precedence. In Chlamydomonas grown under copper-
limiting conditions, copper is reprioritized from the chloroplast
to the mitochondria [81], demonstrating the existence of mecha-
nisms that allow for redistribution of the total cellular copper quota
through dynamic signaling between an organelle and other cellular
compartments.
How do SCOs modulate the generation of such a signal? The
simplest explanation is that their interactions with a protein/molecule
in the IMS occur in a redox-dependent manner that stimulates its
translocation to the cytosol where it in turn regulates copper export,
analogous to the role of cytochrome c in regulating apoptosis.
Cytochrome c binds to APAF-1, causing structural rearrangements
that eventually lead to the formation of the apoptosome, a multi-
subunit complex that recruits and activates caspases, ultimately
causing cell death [82]. APAF-1 is found in a monomeric “locked”
state in the absence of cytochrome c. Binding of cytochrome c triggers
the ﬁrst structural rearrangement in APAF-1 to a ‘semi-open’, auto-
inhibited form. Its transition to the “open” form through nucleotide
exchange precedes the assembly of the multi-subunit complex that
leads to the eventual activation of the caspase by proteolysis. This
pathway represents a multi-layered mechanism that protects the cell
in response to a suicide signal. The major uncertainty with respect to
the mitochondrial regulation of cellular copper export remains the
identiﬁcation of the effector molecule whose activity is ultimately
sensitive to SCO-dependent signaling. At present, ATP7A and ATP7B
are the primary copper exporters, and these proteins have an extended
amino-terminus that has been implicated in binding to a variety of
different cellular proteins (e.g. COMMD1, glutaredoxin, dynactin
subunit p62). The SCO-mediated signaling pathway could affect any
of these interactions in a multi-layer response that stimulates copper
export.
A role for the SCO1 transmembrane domain in regulating the signal
[41] suggests either that it mediates an interaction with an unknown
regulatory factor or that SCO1 is somehow monitoring mitochondrial
copper content with its matrix-localized, N-terminal tail. Matrix
copper levels appear to be largely independent of the energetic status
of the cell and the abundance of CcO and IMS Sod1. However, a link
between mitochondrial copper and CcO assembly factors has been
observed in yeast [72]. Shy1 is the yeast homolog of human SURF1, and
mutations in SURF1 are a common cause of Leigh's syndrome. CcO
assembly factor 1 (Coa1) and Shy1 interact in multiple protein
complexes that are required for the assembly of an early Cox1
intermediate, and may function to promote a Cox1 conformation
that is suitable for the insertion of the heme a3:CuB site [72]. Yeast
lacking either Coa1 or Shy1 exhibit attenuatedmatrix copper pools and
a partial rescue of respiratory growth can be achieved by supplement-
ing themutant cells with high levels of exogenous copper.We propose
that one of the functions of a Coa1/Shy1 complex is to regulate IM
copper transport, thereby linking CcO biogenesis with matrix copper
pool dynamics. The dynamic regulation could be achieved by the
equilibrium of the different protein complexes containing Coa1 and
Shy1. This, like the role of Sco1, is yet another example of CcO assembly
proteins regulating a homeostatic intersection. It also adds to the
growing list of proteins with multiple functions, one of which involves
a critical regulatory role in a given aspect of copper homeostasis.
Why would the organelle have evolved such an elaborate strategy
for the trafﬁcking and storage of copper? The strategy is quite similar
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requirements for copper in the cytoplasm yet takes copper into the
cytoplasm where it is sensed directly by a transcriptional repressor.
The repressor dissociates from an operon encoding a copper exporter
and a periplasmic copper-binding protein required for copper
tolerance. In eukaryotes, mitochondrial copper is retained in a storage
form and regulated release is required for efﬁcient metallation of IMS
enzymes. The storage and regulation of export probably arose from
the limited copper availability in the eukaryotic cytosol and the cell's
need for an immediate source of copper for CcO assembly. As a
consequence, its chelation in a biologically inert ligand was criti-
cal because mitochondrial respiration is a major source of superoxide
production. The superoxide may in turn drive the generation of more
harmful reactive oxygen species [83]. In most organisms, the bulk of
superoxide anion produced on a daily basis by the respiratory chain is
derived from the ubisemiquinone of coenzyme Q (CoQ) [84]. The CoQ
semiquinone generated during the Q-cycle of complex III's catalytic
cycle can react with oxygen to produce superoxide anions in both the
IMS andmatrix [85,86]. Superoxide anions can in turn be converted by
free Cu(I) to the highly reactive hydroxyl radical, or dismutated to
yield hydrogen peroxide by either IMS Sod1 or matrix-localized Sod2.
Thus, the need to complex Cu(I) with a ligand for its storagewithin the
matrix, and to use protein-mediated mechanisms to chaperone Cu(I)
during its subsequent mobilization and trafﬁcking to the IMS may
reﬂect the importance of minimizing Cu-catalyzed production of
deleterious free radicals. The highly regulated trafﬁcking of copper at
the organellar level may also provide a robustmechanism to couple Cu
(I) transport from thematrix to the IMSwith the biogenesis of CcO and
activation of Sod1 under physiological conditions inwhich respiratory
demands are elevated.
In this review, we highlighted the emerging role of mitochondrial
proteins in the regulation of cellular copper export. Future studies that
identify the mechanisms by which interdependent signals allow for
dynamic communication between individual copper trafﬁcking path-
ways will be invaluable to our understanding of the complex, hier-
archical nature of the regulation of cellular copper homeostasis. Such
studies also will ultimately provide further insight into how global
decisions are made about the fate of cellular copper, under both nor-
mal conditions and in response to physiological stimuli.
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